Intellect Neurosciences
About:
Intellect Neurosciences is engaged in the R&D of disease-modifying drugs for the prevention of neurological disorders such as Alzheimer's.
Website: http://intellectns.com
Description:
Intellect Neurosciences Inc. is a New York based biopharmaceutical company engaged in the discovery and development of a new breed of innovative “disease-modifying” therapeutic drugs designed to slow, arrest and ultimately prevent Alzheimer's disease and other serious neurological disorders.
Total Funding Amount:
$2.77M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
New York, New York, United States
Founded Date:
2005-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2010-05-13
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai